Prelude Capital Management’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
5,177
-14,639
-74% -$3.17M 0.08% 275
2026
Q1
$4.12M Buy
+19,816
New +$3.63M 0.32% 75
2024
Q4
Sell
-6,421
Closed -$742K 1532
2024
Q3
$742K Buy
6,421
+688
+12% +$76.8K 0.04% 473
2024
Q2
$634K Buy
+5,733
New +$708K 0.04% 442
2022
Q4
Sell
-2,736
Closed -$338K 1585
2022
Q3
$338K Sell
2,736
-330
-11% -$44.1K 0.01% 818
2022
Q2
$430K Buy
+3,066
New +$429K 0.01% 879
2022
Q1
Sell
-4,965
Closed -$1.02M 2186
2021
Q4
$1.02M Buy
4,965
+561
+13% +$103K 0.03% 590
2021
Q3
$617K Buy
4,404
+2,481
+129% +$372K 0.02% 782
2021
Q2
$295K Sell
1,923
-111
-5% -$15.5K 0.01% 1201
2021
Q1
$287K Buy
+2,034
New +$292K 0.01% 1173
2020
Q1
Sell
-440
Closed -$51K 1983
2019
Q4
$51K Buy
+440
New +$48.3K ﹤0.01% 1331
2019
Q1
Sell
-48
Closed -$4K 2136
2018
Q4
$4K Buy
+48
New +$3.99K ﹤0.01% 1655
2017
Q2
Sell
-468
Closed -$34K 1822
2017
Q1
$34K Buy
+468
New +$32.7K ﹤0.01% 1152
2016
Q4
Sell
-567
Closed -$33K 1757
2016
Q3
$33K Buy
+567
New +$30.6K ﹤0.01% 1193
2015
Q1
Sell
-800
Closed -$38K 2150
2014
Q4
$38K Buy
+800
New +$35.3K 0.01% 1433
2014
Q3
Sell
-800
Closed -$39K 2096
2014
Q2
$39K Buy
+800
New +$38.1K 0.01% 1489

Other funds holding SLAB

Prelude Capital Management's SLAB Position: Q2 2026 in Review

Prelude Capital Management reduced its Silicon Laboratories (SLAB) stake by 74% in Q2 2026, selling an estimated $3.17M and leaving 5,177 shares worth $1.13M. The position accounts for 0.08% of the portfolio, ranked #275.

Prelude Capital Management first reported a position in SLAB in Q2 2014 and has held it in 16 quarters since. The position peaked at $4.12M in Q1 2026. 352 funds tracked by Wall St. Rank hold SLAB as of Q2 2026.

  • Prelude Capital Management held 5,177 shares of Silicon Laboratories worth $1.13M as of Q2 2026.
  • Prelude Capital Management sold 14,639 Silicon Laboratories shares in Q2 2026, an estimated $3.17M.
  • Silicon Laboratories made up 0.08% of Prelude Capital Management's portfolio in Q2 2026, its #275 holding.
  • Prelude Capital Management first reported a position in Silicon Laboratories in Q2 2014 and has held it in 16 quarters since.
  • Prelude Capital Management's Silicon Laboratories position peaked at $4.12M in Q1 2026.
  • 352 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.